California state Sen. Jeff Stone, a former independent pharmacist himself, had one message for independent pharmacists during the McKesson ideaShare 2015 Public Policy session in San Diego — don’t just vote, get involved.
The National Association of Chain Drugs Stores celebrated Albertsons/Safeway and Kinney Drugs for the companies’ political advocacy and grassroots activities at NACDS Total Store Expo, Friday evening at the NACDS Political Involvement reception.
NACDS president and CEO Steve Anderson discusses the NACDS RxImpact grassroots advocacy program, which can serve as a resource for pharmacy professionals to learn how to engage and educate lawmakers about key pharmacy issues.
“A profound, and likely irreversible, impact on the business of health care.” That’s the effect the Patient Protection and Affordable Care Act already has had in the five years since its passage and enactment into law, PricewaterhouseCoopers said.
Variations in how states have implemented the insurance eligibility provisions of the Affordable Care Act have “led to highly diverse, geographically dependent health reform experiences,” noted PwC’s Health Research Institute, and made the states “key players in health reform.”
Health insurers are responding by “changing their fundamental business model,” PwC’s Health Research Institute noted in its report on U.S. health industry trends in the wake of the Affordable Care Act.
Like the regulatory changes that spawned the modern era of telecommunications in the mid-1990s, the health reform law has unleashed a tide of innovation and competitive disruption that’s rippling through the nation’s shifting healthcare system.
Driven by the funding priorities of health reform under the Affordable Care Act, primary care physicians once again are moving to the center of American health care.
Health reform is spawning new risk-sharing patient-care initiatives that are shifting the focus of health delivery.
The August Kaiser Health Tracking Poll, which was released Thursday, found that bipartisan majorities of the public are in favor of lowering the costs of prescription drugs, and that opinions of the Affordable Care Act remain "largely unchanged."